# Revvity
Who / What
Revvity, Inc. is an American biotechnology company specializing in life sciences and diagnostics. It primarily serves the pharmaceutical and biotechnology industries by offering solutions related to cell therapy, gene therapy, and other advanced medical developments.
---
Background & History
Revvity traces its origins back to PerkinElmer, a long-standing company operating across various business sectors, including scientific instrumentation and services. The company underwent restructuring in recent years to focus on life sciences diagnostics and therapeutic advancements. Its strategic pivot aligns with emerging trends in gene and cell therapy, positioning it as a key player in the evolving biotech landscape.
---
Why Notable
Revvity’s prominence stems from its role in facilitating innovations within pharmaceutical and biotechnology sectors, particularly in areas like next-generation sequencing (NGS) and precision medicine. By leveraging PerkinElmer’s legacy expertise, Revvity has positioned itself as a critical enabler for cutting-edge therapeutic developments, influencing how cell and gene therapies are researched, developed, and commercialized.
---
In the News
As of recent reports, Revvity continues to expand its partnerships with leading biotech firms, driving advancements in diagnostics and therapeutic workflows. Its focus on streamlining processes for emerging therapies has garnered attention from investors and industry analysts, highlighting its growing relevance in the life sciences sector amid rapid technological progress.
---
Key Facts
---
